LVCE Stock Overview
LiveCare, Inc. focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
LiveCare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.63 |
| 52 Week High | US$1.50 |
| 52 Week Low | US$0.02 |
| Beta | -0.90 |
| 1 Month Change | 26.51% |
| 3 Month Change | 26.51% |
| 1 Year Change | -54.68% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -68.50% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| LVCE | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -10.0% | -2.2% | -3.7% |
| 1Y | -54.7% | 11.6% | 20.5% |
Return vs Industry: LVCE underperformed the US Pharmaceuticals industry which returned 11.7% over the past year.
Return vs Market: LVCE underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| LVCE volatility | |
|---|---|
| LVCE Average Weekly Movement | 37.3% |
| Pharmaceuticals Industry Average Movement | 9.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LVCE's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine LVCE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Cornelius Rockwell | www.livecarehealth.com |
LiveCare, Inc. focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach. The company is a real-time health, analytics, service, and monitoring company that provides persons with type II diabetes with solutions. The company was incorporated in 2018 and is based in Venice, Florida.
LiveCare, Inc. Fundamentals Summary
| LVCE fundamental statistics | |
|---|---|
| Market cap | US$32.05m |
| Earnings (TTM) | -US$10.38m |
| Revenue (TTM) | US$3.60m |
8.9x
P/S Ratio-3.1x
P/E RatioIs LVCE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LVCE income statement (TTM) | |
|---|---|
| Revenue | US$3.60m |
| Cost of Revenue | US$11.85m |
| Gross Profit | -US$8.25m |
| Other Expenses | US$2.13m |
| Earnings | -US$10.38m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.20 |
| Gross Margin | -229.09% |
| Net Profit Margin | -288.26% |
| Debt/Equity Ratio | -109.8% |
How did LVCE perform over the long term?
See historical performance and comparison